Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
EditForce, a Japan-based creator of DNA and RNA drug development technology, raised $4.5m in funding yesterday from structural wood members manufacturer Yoshimei, MP Healthcare Venture Management and FFG Venture Investment. The commitment is an extension to the $7.3m round led by Newton Biocapital in May 2021, when University of Tokyo Edge Capital (UTEC), Itochu Technology Ventures, a subsidiary of trading group Itochu, telecoms firm KDDI and Global Brain also invested. UTEC and Itochu Technology Ventures contributed to an $7.8m series B2 round in 2019 together with energy utility Kansai Electric Power’s K4 Ventures unit, QB Capital, Newton Biocapital and Japan’s Science and Technology Agency. UTEC and chemical producer Kisco had invested $1.5m in the company in 2016.
Epigno, a Japan-based developer of a hospital staff management tool, has raised ¥250m ($2.2m) from medical information provider M3. The company previously raised $929,000 in funding from Tohoku University Venture Partners,…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
